Please login to the form below

Not currently logged in
Email:
Password:

ICON boosts leadership teams

Dr Andrew Garrett, Dr Paul McCracken and Jim Carroll join

ICON Dr Andrew GarrettPharmaceutical service provider ICON has boosted its scientific operations, medical imaging and real world evidence leadership teams with three new senior appointments.

Dr Andrew Garrett (pictured right) joins ICON as executive vice president of scientific operations, with responsibility for the firm's global strategy and operational execution of its biostatistics and programming, pharmacovigilance, regulatory and medical affairs, medical writing, medical imaging and interactive technologies.

He has over 30 years of experience in pharmaceutical and contract research organisation (CRO) roles, joining from Quintiles where he led its global clinical analysis and reporting services group.

ICON Dr Paul McCrackenDr Paul McCracken (pictured left) has been appointed as vice president of medical imaging, bringing over 20 years of expertise in applying imaging and biomarkers to drug discovery and development across a range of therapeutic areas.

Most recently, Dr McCracken led the Imaging Centre of Excellence at Eisai, having previously worked at Merck Research Laboratories developing preclinical and translational imaging biomarkers and strategies to assess new molecular and biologic entities.

Also joining ICON's leadership team, Jim Carroll (pictured below right) becomes vice president of real world evidence (RWE), leading the company's RWE Center of Excellence in the development of market access solutions.

ICON Jim CarrollCarroll has over 20 years of CRO and pharmaceutical experience, and joins ICON from inVentiv Health where he led its real world data (RWD)-driven service unit. Previously, Carroll oversaw IMS Health's RWD analytic solutions offering, helping to improve decision outcomes throughout a product's lifecycle.

Dr Steve Cutler, ICON's chief operating officer, said: “I'm delighted to welcome Andrew, Paul and Jim to the ICON team.

“The bring a wealth of scientific operational and commercialisation expertise to ICON which will help us to advance our clients' products through their development pipelines and also drive their commercial success.”

20th October 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics